All News about Enanta Pharmaceutica
![](https://cdn2.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2021/analyst_ratings_image_1661.jpeg?width=720)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/aapharma_2206.png)
![](https://mms.businesswire.com/media/20211019005265/en/789698/5/enanta_logo-blue.jpg)
![](https://cdn2.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2021/analyst_ratings_image_1129.jpeg?width=720)
![](https://mms.businesswire.com/media/20211006005607/en/789698/5/enanta_logo-blue.jpg)
Via Business Wire
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/cells-1872666_1920_84.jpg)
Via Benzinga
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/cells-1872666_1920_98.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/medicine-1309148_1920_378.jpg)
![](https://cdn2.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2021/analyst_ratings_image_1092.jpeg?width=720)
![](https://mms.businesswire.com/media/20211005005361/en/789698/5/enanta_logo-blue.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/laboratory-2815640_1920_1_12.jpg)
Via Benzinga
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/aapharma_2101.png)
![](https://mms.businesswire.com/media/20211004005192/en/789698/5/enanta_logo-blue.jpg)
Enanta Pharmaceuticals Provides Update on NASH FXR Agonist Programs
October 04, 2021
Via Business Wire
![](https://mms.businesswire.com/media/20211001005120/en/789698/5/enanta_logo-blue.jpg)
![](https://mms.businesswire.com/media/20210907005001/en/900425/5/4368511_enanta_logo-blue.jpg)
Enanta Pharmaceuticals to Participate in Investor Conferences in September
September 07, 2021
Via Business Wire
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/cells-1872666_1920_92.jpg)
Via Benzinga
![](https://mms.businesswire.com/media/20210823005010/en/900466/4/Yujiro_Hata_HeadShot.jpg)
![](https://cdn2.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2021/analyst_ratings_image_376.jpeg?width=720)
![](https://mms.businesswire.com/media/20210816005078/en/789698/5/enanta_logo-blue.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/medicine-1309148_1920_369.jpg)
![](https://g.foolcdn.com/editorial/images/1/featured-transcript-logo-template.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/sites/all/themes/bz2/images/bz-icon.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/cells-1872666_1920_91.jpg)
![](https://mms.businesswire.com/media/20210805005808/en/789698/5/enanta_logo-blue.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/medicine-1309148_1920_368.jpg)
![](https://mms.businesswire.com/media/20210805005138/en/789698/5/enanta_logo-blue.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/cells-1872666_1920_90.jpg)
Via Benzinga
![](https://mms.businesswire.com/media/20210729005136/en/789698/5/enanta_logo-blue.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.